Robb D. Kociol, MD, has joined the Division of Cardiovascular Medicine and the
CardioVascular Institute at Beth Israel Deaconess Medical Center where he has been appointed Director of the Ventricular Assist Device Program and Associate Director of Advanced Heart Failure.
Kociol comes to BIDMC after completing a fellowship in advanced heart failure and transplant at Tufts Medical Center in Boston. He specializes in treating patients with heart failure and leads a multidisciplinary team that is spearheading the development of a new left ventricular assist device (LVAD) program.
Under Kociol's direction, the LVAD program significantly broadens the range of treatment options available at BIDMC's CardioVascular Institute for patients with advanced heart failure. CVI patients will be able to receive LVAD implants both as a destination therapy and as a bridge to transplantation.
A graduate of the Boston University School of Medicine, Kociol was a resident at Brigham and Women's Hospital in Boston before completing a cardiology fellowship and a research fellowship at Duke University Hospital in Durham, NC.
Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School, and currently
ranks third in National Institutes of Health funding among independent hospitals nationwide. BIDMC is clinically affiliated with the Joslin Diabetes Center and is a research partner of Dana-Farber/Harvard Cancer Center. BIDMC is the official hospital of the Boston Red Sox. For more information, visit